Reading this on a mobile device? Try our optimized mobile version here:

March 6, 2013
Sign upForwardArchiveAdvertise
News for diabetes health professionals

  Diabetes in Focus 
  • Study: ADT tied to higher A1C levels in men with diabetes
    Male diabetes patients who underwent androgen deprivation therapy for prostate cancer showed higher A1C at two years compared with those who did not receive ADT, a study found. "Men with diabetes who start ADT should be counseled about the potential need for intensification of diabetes therapy and should have their [A1C] levels monitored during therapy, especially if they continue on long-term ADT," researchers wrote in the journal European Urology. MedWire News (U.K.) (3/4) LinkedInFacebookTwitterEmail this Story
  Nutrition & Wellness 
  • N.J. towns increase emphasis on healthy living
    Towns in northern New Jersey, encouraged by TV programs such as "The Biggest Loser," are beginning their own wellness initiatives and using private and public incentives. The Mayors Wellness Campaign involves 344 of the state's 566 municipalities and last week named River Vale and Paramus as its "Healthy Towns" of 2013. The Record (Hackensack, N.J.) (3/3) LinkedInFacebookTwitterEmail this Story
  Practice Update 
  • Research ties public reporting to quality improvement
    A study in Health Affairs revealed doctor groups that reported their quality data publicly were compelled to improve performance. The research evaluated 20 physician groups participating in the Wisconsin Collaborative for Healthcare Quality and found overall improvement on reported metrics and better performance on certain publicly reported testing metrics than comparison groups. (3/5) LinkedInFacebookTwitterEmail this Story
  Trends & Technology 
  • FDA OKs Bluetooth-enabled blood glucose monitor from LifeScan
    LifeScan has received FDA approval for its OneTouch Verio Synch system, which is used to monitor blood glucose in diabetes patients. The technology uses Bluetooth connectivity to allow patients to wirelessly receive personalized data, including a 14-day summary of glucose test outcomes, via an iPad, iPhone or iPod touch. Healio/Endocrine Today (3/4) LinkedInFacebookTwitterEmail this Story
Every time you spend money, you're casting a vote for the kind of world you want."
--Anna Lappé,
American writer, speaker and activist

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Director:  Aaron Kern (202) 407-7866
A powerful website for SmartBrief readers including:
 Recent DiabetesPro SmartBrief Issues:   Lead Editor:  Kathryn Doherty
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information